Clovis Oncology to Present at the Credit Suisse 27th Annual Healthcare Conference

BOULDER, Colo.–(BUSINESS WIRE)–Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Patrick J.
Mahaffy, Chief Executive Officer and President, will present at the 27th
Annual Healthcare Conference on Wednesday, November 14, 2018 at 11:30 AM
Mountain Time. The conference will be held at the Phoenician in

A live webcast of the presentation can be accessed through the investor
relations section of the Company’s website at
Following the live presentation, a replay of the webcast will be
available on the Company’s website for 30 days.

About Clovis Oncology

Clovis Oncology, Inc. is a biopharmaceutical company focused on
acquiring, developing and commercializing innovative anti-cancer agents
in the U.S., Europe and additional international markets. Clovis
Oncology targets development programs at specific subsets of cancer
populations, and simultaneously develops, with partners, diagnostic
tools that direct a compound in development to the population that is
most likely to benefit from its use. Clovis Oncology is headquartered in
Boulder, Colorado, and has additional offices in San Francisco,
California and Cambridge, UK. Please visit
for more information.


Clovis Oncology, Inc.
Anna Sussman, 303-625-5022
Burkart, 303-625-5023

Sky Optics Media drone video